|
Volumn 146, Issue 5, 2007, Pages 376-389
|
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
ETORICOXIB;
IBUPROFEN;
LUMIRACOXIB;
MELOXICAM;
MISOPROSTOL;
NAPROXEN;
PLACEBO;
ROFECOXIB;
SULINDAC;
VALDECOXIB;
NONSTEROID ANTIINFLAMMATORY AGENT;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER REGISTRY;
CANCER SCREENING;
CARDIOVASCULAR DISEASE;
CASE CONTROL STUDY;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COCHRANE LIBRARY;
COHORT ANALYSIS;
COLORECTAL ADENOMA;
COLORECTAL CANCER;
COMPARATIVE STUDY;
CONFIDENCE INTERVAL;
DIGESTIVE SYSTEM PERFORATION;
DIGESTIVE SYSTEM ULCER;
DRUG EFFICACY;
DRUG USE;
EMBASE;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL OBSTRUCTION;
HEART INFARCTION;
HUMAN;
MEDLINE;
PREVENTIVE HEALTH SERVICE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
QUALITY CONTROL;
REVIEW;
RISK FACTOR;
RISK REDUCTION;
STROKE;
SYSTEMATIC REVIEW;
ULCER;
UNITED STATES;
ADENOMA;
ADULT;
CHEMICALLY INDUCED DISORDER;
COLON POLYP;
COLORECTAL TUMOR;
FEMALE;
GASTROINTESTINAL DISEASE;
INCIDENCE;
MALE;
MORTALITY;
ADENOMA;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CARDIOVASCULAR DISEASES;
COLONIC POLYPS;
COLORECTAL NEOPLASMS;
CYCLOOXYGENASE 2 INHIBITORS;
FEMALE;
GASTROINTESTINAL DISEASES;
HUMANS;
INCIDENCE;
MALE;
PRIMARY PREVENTION;
UNITED STATES;
|
EID: 33947533150
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-146-5-200703060-00010 Document Type: Review |
Times cited : (298)
|
References (86)
|